A claimed surge in gene therapy and longevity research

In a September 28, 2026 post, a user claimed that two more one-shot gene therapies had received FDA approval and a personalized mRNA cancer vaccine had beaten Keytruda in Phase 3 during roughly the previous 90 days. They argued that biotech progress is accelerating—and called for it to move faster.